Category Innovative Licensing and Access Pathway

Last updated: 28 February 2022 See updates at the end of this post. The UK MHRA has published guidance on the the Innovative Licensing and Access Pathway (ILAP) for medicines. It aims to accelerate the time to market, facilitating patient…

Last updated: 28 Sebruary 2022 See updates at the end of the post. The UK MHRA has recently published the Target Development Profile (TDP) Toolkit to accompany the Innovative Licensing and Access Pathway (ILAP) licensing route available since the beginning…